Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury

AIM: To investigate the efficacy and safety of a dipeptidyl peptidase-4 inhibitor, sitagliptin, for treating diabetes mellitus complicated by chronic liver injury. METHODS: Sitagliptin was administered for 13.7 ± 10.1 months to 122 patients with DM complicated by chronic liver injury (including 19 p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Springerplus
Asıl Yazarlar: Asakawa, Masahiro, Mitsui, Hiroshi, Akihisa, Momoko, Sekine, Tetsuo, Niitsu, Yoshihiro, Kobayashi, Arisa, Miyake, Atsuko, Hashimoto, Naoaki, Kawamura, Mitsunobu, Ogawa, Yoshihiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4501339/
https://ncbi.nlm.nih.gov/pubmed/26191473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1135-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller